In our study, the MMP-2-735C/T genotype frequencies were found to be CC 74.1%, CT 23.2%, and TT 0.9% in the lung cancer patients group, and CC 77.0%, CT 18.0%, and TT 5.0% in the control group, respectively. The gene discussed is MMP2; the disease is lung carcinoma.